Novartis is using data analytics to research and develop new treatments . Dr Luca Finelli , head of predictive analysis and design , global drug development , said that the company 's advanced analytics platform Nerve Live can generate insights that were not previously possible when information was kept in different silos . Using machine learning and cognitive computing algorithms , the platform can use past and present information from Novartis 's massive data pool to make performance predictions , for example , for clinical trials , helping researchers choose the best drugs and countries , and making faster and more informed decisions about treatments .
Novartis is using data analytics to research and develop new treatments. Dr Luca Finelli, head of predictive analytics and design, global drug development, said that the company's advanced analytics platform Nerve Live can generate insights that were not previously possible when information was kept in different silos. Using machine learning and cognitive computing algorithms, the system can use past and present information from Novartis's massive data pool to make performance predictions, for example, for clinical studies, helping researchers choose the best sites and countries, and make faster and more informed decisions about trials.